Tim Raine

18.7k total citations · 3 hit papers
97 papers, 4.9k citations indexed

About

Tim Raine is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Tim Raine has authored 97 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Genetics, 38 papers in Epidemiology and 24 papers in Immunology. Recurrent topics in Tim Raine's work include Inflammatory Bowel Disease (43 papers), Microscopic Colitis (31 papers) and Eosinophilic Esophagitis (9 papers). Tim Raine is often cited by papers focused on Inflammatory Bowel Disease (43 papers), Microscopic Colitis (31 papers) and Eosinophilic Esophagitis (9 papers). Tim Raine collaborates with scholars based in United Kingdom, United States and Canada. Tim Raine's co-authors include Marcus Harbord, Rami Eliakim, Herbert Tilg, Alexander R. Moschen, Anne Cooke, Fernando Magro, Jimmy K. Limdi, Ailsa Hart, Johan Burisch and Paolo Gionchetti and has published in prestigious journals such as Cell, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Tim Raine

86 papers receiving 4.9k citations

Hit Papers

Third European Evidence-b... 2017 2026 2020 2023 2017 2017 2018 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
    2017 1.3k citations Ailsa Hart, Tim Raine et al. Journal of Crohn s and Colitis profile →
  2. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
    2017 854 citations Tim Raine et al. Journal of Crohn s and Colitis profile →
  3. IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting
    2018 353 citations Tim Raine et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Tim Raine 2.8k 2.0k 1.4k 1.0k 776 97 4.9k
Tariq Ahmad 2.9k 1.1× 1.9k 1.0× 1.6k 1.2× 1.4k 1.4× 687 0.9× 131 5.2k
Stuart Bloom 2.4k 0.9× 1.6k 0.8× 1.2k 0.9× 1.3k 1.3× 583 0.8× 114 4.4k
Atsushi Sakuraba 2.0k 0.7× 1.6k 0.8× 1.2k 0.9× 892 0.9× 573 0.7× 153 4.2k
Charlie W. Lees 2.5k 0.9× 1.7k 0.9× 752 0.6× 1.0k 1.0× 813 1.0× 133 4.0k
Thomas Ochsenkühn 2.8k 1.0× 1.9k 1.0× 1.5k 1.1× 1.6k 1.6× 520 0.7× 99 5.0k
Jean–Paul Achkar 3.0k 1.1× 1.9k 1.0× 2.0k 1.5× 1.4k 1.4× 1.2k 1.6× 64 5.4k
Sander van Deventer 2.5k 0.9× 1.6k 0.8× 1.6k 1.2× 1.0k 1.0× 1.1k 1.4× 62 4.9k
Taku Kobayashi 2.6k 0.9× 1.6k 0.8× 1.8k 1.3× 996 1.0× 1.4k 1.9× 161 5.3k
Jørn Brynskov 3.9k 1.4× 2.7k 1.4× 1.9k 1.4× 1.3k 1.3× 665 0.9× 123 5.6k
Christian Maaser 2.7k 1.0× 2.1k 1.1× 1.1k 0.8× 1.8k 1.8× 665 0.9× 117 5.6k

Countries citing papers authored by Tim Raine

Since Specialization
Citations

This map shows the geographic impact of Tim Raine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Raine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Raine more than expected).

Fields of papers citing papers by Tim Raine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Raine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Raine. The network helps show where Tim Raine may publish in the future.

Co-authorship network of co-authors of Tim Raine

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Raine. A scholar is included among the top collaborators of Tim Raine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Raine. Tim Raine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Gareth, Tim Raine, Adam J. Byrne, et al.. (2025). DOP112 Inflammation-associated monocytes express ACOD1 to curtail inflammatory behaviour in IBD and experimental colitis. Journal of Crohn s and Colitis. 19(Supplement_1). i288–i289.
2.
Panousis, Nikolaos I., Andrew Knights, Natsuhiko Kumasaka, et al.. (2025). Splicing QTL mapping in stimulated macrophages associates low-usage splice junctions with immune-mediated disease risk. Nature Communications. 16(1). 7205–7205. 1 indexed citations
3.
Raine, Tim, Silvio Danese, Stefan Schreiber, et al.. (2024). DOP64 Steroid-sparing effect of risankizumab vs ustekinumab in patients with moderately to severely active Crohn’s Disease: Post hoc results from the phase 3b SEQUENCE trial. Journal of Crohn s and Colitis. 18(Supplement_1). i189–i189. 2 indexed citations
4.
Menzies‐Gow, Andrew, Trung N. Tran, Victoria Carter, et al.. (2024). Trends in Systemic Glucocorticoid Utilization in the United Kingdom from 1990 to 2019: A Population-Based, Serial Cross-Sectional Analysis. PubMed. Volume 15. 53–64. 7 indexed citations
5.
Goode, Elizabeth C., Laura Fachal, Nikolaos Panousis, et al.. (2024). Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk loci. Nature Communications. 15(1). 9594–9594. 1 indexed citations
6.
Al‐Bawardy, Badr, Eman Al Sulais, Moawia M. Mukhtar, Ailsa Hart, & Tim Raine. (2024). P711 Outcomes of Outpatient Biologic Exposed Patients Hospitalized with Severe Ulcerative Colitis. Journal of Crohn s and Colitis. 18(Supplement_1). i1331–i1331. 1 indexed citations
7.
Raine, Tim, Yoh Ishiguro, David T. Rubin, et al.. (2023). Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme. Journal of Crohn s and Colitis. 18(5). 695–707. 4 indexed citations
8.
Higham, James P., et al.. (2023). KV7 but not dual small and intermediate KCa channel openers inhibit the activation of colonic afferents by noxious stimuli. American Journal of Physiology-Gastrointestinal and Liver Physiology. 325(5). G436–G445. 2 indexed citations
9.
Panaccione, Remo, Wan‐Ju Lee, Kristina Kligys, et al.. (2023). Dose Escalation Patterns of Advanced Therapies in Crohn’s Disease and Ulcerative Colitis: A Systematic Literature Review. Advances in Therapy. 40(5). 2051–2081. 13 indexed citations
10.
Tucker, Laura, Alexander Allen, David Chandler, et al.. (2022). The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Lara D. Veeken. 61(9). e255–e266. 9 indexed citations
11.
Tucker, Laura, Alexander Allen, David Chandler, et al.. (2022). Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs. Lara D. Veeken. 61(9). 3514–3520. 3 indexed citations
12.
13.
14.
Tillett, William, Alexander Allen, Laura Tucker, et al.. (2020). Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope. Lara D. Veeken. 60(4). 1588–1592. 3 indexed citations
15.
16.
17.
Danese, Silvio, Gionata Fiorino, Tim Raine, et al.. (2016). ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update. Journal of Crohn s and Colitis. 11(1). 26–34. 171 indexed citations
18.
Crosby, Alexi, Elaine Soon, Frances M. Jones, et al.. (2015). Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2 +/− Mice with Schistosomiasis. American Journal of Respiratory and Critical Care Medicine. 192(11). 1355–1365. 20 indexed citations
19.
Gibbons, Deena L., Lucie Abeler‐Dörner, Tim Raine, et al.. (2011). Cutting Edge: Regulator of G Protein Signaling-1 Selectively Regulates Gut T Cell Trafficking and Colitic Potential. The Journal of Immunology. 187(5). 2067–2071. 62 indexed citations
20.
Gibbons, Deena L., Tim Raine, Lucie Abeler‐Dörner, et al.. (2010). RGS1 is a key regulator of human T cell migration and a potential target for therapy in Inflammatory Bowel Disease (IBD). Immunology. 131. 75–75. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tariq Ahmad Breakdown of academic impact, for papers by Stuart Bloom Breakdown of academic impact, for papers by Atsushi Sakuraba Breakdown of academic impact, for papers by Charlie W. Lees Breakdown of academic impact, for papers by Thomas Ochsenkühn Breakdown of academic impact, for papers by Jean–Paul Achkar Breakdown of academic impact, for papers by Sander van Deventer Breakdown of academic impact, for papers by Taku Kobayashi Breakdown of academic impact, for papers by Jørn Brynskov Breakdown of academic impact, for papers by Christian Maaser
Rankless by CCL
2026